Comparison of clinical characteristics of opium-induced and independent major depressive disorder

American Journal of Drug and Alcohol Abuse

Volumn 34, Issue 4, 2008, Pages 415-421

  Mowla, Arash ^a,c   Kianpor, Moshen ^b   Bahtoee, Mehrzad ^a   Sabayan, Behnam ^b   Chohedri, Abdul Hamid ^b  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Bushehr Technical College   (Iran)

Author keywords

Clinical characteristic; Depression; Opium; Substance

Indexed keywords

OPIATE;

ADULT; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; GASTROINTESTINAL DISEASE; HAMILTON SCALE; HUMAN; INTROSPECTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOTOR RETARDATION; OCCUPATIONAL DISEASE; PHYSICAL DISEASE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEXUAL DYSFUNCTION; SOCIAL PROBLEM;

ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 46249119179     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990802122325     Document Type: Article

References (18)

1. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry 2004; 61:807-816.
2. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders. Am J Orthopsychiatry 1996; 66:17-31.
3. Goetzel RZ, Hawkins K, Ozminkowski RJ. The health and productivity cost burden of the "top 10" physical and mental conditions affecting six large US employers in 1999. J Occup Environ Med 2003; 45:5-14.
4. Hirschfield R, Hasin D, Keller M, Endicott J, Wunder J. Depression and alcoholism: Comorbidity in a longitudinal study. In: Maser J, Cloninger C, eds. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990:293-304.
5. Merikangas K, Stevens DE. Substance abuse among women: familial factors and comorbidity. In: Wetherington CL, Roman AB, eds. Drug Addiction Research and Health of Women. Bethesda, Md: National Institute on Drug Abuse; 1998; 245-269.
6. Schuckit MA. Drug and alcohol abuse: A clinical guide to diagnosis and treatment, 6th ed. New York: Springer; 2006.
7. Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, et al. The characteristics of heroin users entering treatment: Findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev 2005; 24(5):411-418.
8. Ahmadi J, Toobaee S, Kharras M. Psychiatric disorders in opioid dependents. Int J Soc Psychiatry 2003; 49(3):185-191.
9. Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Addiction, 2006; 101:76-88.
10. Patten SB, Lamarre CJ. Can drug-induced depressions be identified by their clinical features? Can J Psychiatry 1992; 37:213-215.
11. Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: Association with common psychiatric disorders. Pain. 2005; 15 119(1-3):95-103.
12. Montgomery SA. Is there a role for a pure noradrenergic drug in the treatment of depression? Eur Neuropsychopharmacol 1997; 7:3-9.
13. Healy D, McMonagle T. The enhancement of social functioning as a therapeutic principle in the management of depression. J Psychopharmacol 1997; 11:25-31.
14. Montgomery SA. The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 1989; 4:113-119.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
16. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: The hopelessness scale. J Consult Clin Psychol 1974; 6:861-865.
17. Davis LL, Frazier E, Husain MM, Warden D, Trivedi M, Fava M, et al. Substance use disorder comorbidity in major depressive disorder: A confirmatory analysis of the STAR*D cohort. Am J Addict 2006; 15(4):278-285.
18. Davis LL, Rush JA, Wisniewski SR, Rice K, Cassano P, Jewell ME, et al. Substance use disorder comorbidity in major depressive disorder: An exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort. Compr Psychiatry 2005; 46(2):81-9: p. 570.